Trials / Completed
CompletedNCT04602286
How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample)
An Online Randomized Controlled Trial Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Pain Experience in Adults With Recurrent and Chronic Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 373 (actual)
- Sponsor
- The University of Queensland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Both mindfulness meditation and expectancy effects are known to reduce pain intensity, pain unpleasantness and pain catastrophizing, but it is unknown whether and how expectancy effects contribute to the overall effect of mindfulness meditation on these outcomes, especially during significant global events such as the coronavirus pandemic. This study includes four interrelated aims that will probe these effects and interactions.
Detailed description
As many as 1 in 4 Australians experience chronic pain. Further, it is yet unknown the effects of the Coronavirus (COVID-19) pandemic on Australians with or at risk of chronic pain. There is a critical need for the development and evaluation of fast-acting non-pharmaceutical treatments that have the capacity to target the multidimensional nature of chronic pain. This study will investigate how mindfulness meditation and common expectancy effects interact and will further characterise the mechanisms underlying these effects. Results will ultimately lead to targeted interventions that more effectively engage cognitive mechanisms associated with pain attenuation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Meditation (1 x 20-minute guided audio training) | Participants will complete a single session of 20-minutes online guided audio-delivered training session of one of the four conditions. |
Timeline
- Start date
- 2020-10-28
- Primary completion
- 2021-09-28
- Completion
- 2021-09-28
- First posted
- 2020-10-26
- Last updated
- 2023-02-17
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04602286. Inclusion in this directory is not an endorsement.